Cargando...
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
BACKGROUND: SARS-CoV-2 is a novel coronavirus first recognized in late December 2019 that causes coronavirus disease 19 (COVID-19). Due to the highly contagious nature of SARS-CoV-2, it has developed into a global pandemic in just a few months. Antibody testing is an effective method to supplement t...
Guardado en:
| Publicado en: | BMC Immunol |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7887538/ https://ncbi.nlm.nih.gov/pubmed/33596826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-021-00404-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|